Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 17 Oct 2023

Plasmodium immunotherapy combined with gemcitabine has a synergistic inhibitory effect on tumor growth and metastasis in murine Lewis lung cancer models

in Cancer Immunity and Immunotherapy

Xiao Chen
Zhu Tao
Yun Liang
Meng Ma
Dickson Adah
Wenting Ding
Lili Chen
Xiaofen Li
Linglin Dai
Songwe Fanuel

Frontiers in Oncology

doi 10.3389/fonc.2023.1181176

2,640 views
5 citations

Original Research

Published on 17 Oct 2023

Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience

in Cancer Immunity and Immunotherapy

Enikő Sebestyén
Nóra Major
Levente Bodoki
Attila Makai
Ingrid Balogh
Gábor Tóth
Zsuzsanna Orosz
Péter Árkosy
Attila Vaskó
Katalin Hodosi

Frontiers in Oncology

doi 10.3389/fonc.2023.1252215

2,115 views
4 citations

Review

Published on 17 Oct 2023

Spatial transcriptomics in glioblastoma: is knowing the right zip code the key to the next therapeutic breakthrough?

in Cancer Immunity and Immunotherapy

Jack M. Shireman
Lingxin Cheng
Amiti Goel
Diogo Moniz Garcia
Sanil Partha
Alfredo Quiñones-Hinojosa
Christina Kendziorski
Mahua Dey

Frontiers in Oncology

doi 10.3389/fonc.2023.1266397

6,007 views
2 citations

Review

Published on 12 Oct 2023

FTO plays a crucial role in gastrointestinal cancer and may be a target for immunotherapy: an updated review

in Cancer Immunity and Immunotherapy

Xiangqing Ren
Xiaolong Tang
Tian Huang
Zenan Hu
Yuping Wang
Yongning Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.1241357

3,229 views
5 citations

Brief Research Report

Published on 09 Oct 2023

Human antibody VH domains targeting uPAR as candidate therapeutics for cancers

in Cancer Immunity and Immunotherapy

Xiaojie Chu
Wei Li
Margaret G. Hines
Ilya Lyakhov
John W. Mellors
Dimiter S. Dimitrov

Frontiers in Oncology

doi 10.3389/fonc.2023.1194972

2,707 views
3 citations

Case Report

Published on 06 Oct 2023

Long-term survival with a combination of immunotherapy, anti-angiogenesis, and traditional radiotherapy in brain metastatic small cell lung cancer: a case report

in Cancer Immunity and Immunotherapy

Yan-yan Long
Jing Chen
Yue Xie
Ying Wang
Yong-zhong Wu
Ying Xv
Ke-gui Weng
Wei Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.1209758

2,508 views
1 citation

Original Research

Published on 05 Oct 2023

Immunotherapy strategies for EGFR-mutated advanced NSCLC after EGFR tyrosine-kinase inhibitors failure

in Cancer Immunity and Immunotherapy

Xingyuan Li
Huayan Huang
Yingjia Sun
Qing Jiang
Yongfeng Yu

Frontiers in Oncology

doi 10.3389/fonc.2023.1265236

2,950 views
3 citations

Case Report

Published on 05 Oct 2023

PD-1 combined with lenvatinib and TACE for the transformational treatment of hepatocellular carcinoma combined with portal vein tumor thrombus: a case report and literature review

in Cancer Immunity and Immunotherapy

Sheng Liu
Rui Xiong
Chuanyi Duan
Jiang Tang
Tao Yin
Sisi Dai

Frontiers in Oncology

doi 10.3389/fonc.2023.1199143

2,029 views
1 citation

Case Report

Published on 05 Oct 2023

Case Report: Resolution of remitting seronegative symmetrical synovitis with pitting edema during nivolumab therapy for gastric cancer

in Cancer Immunity and Immunotherapy

Hirofumi Ohmura
Moe Kondo
Masato Uenomachi
Hiroshi Ariyama
Mamoru Ito
Kenji Tsuchihashi
Masahiro Ayano
Hiroaki Niiro
Koichi Akashi
Eishi Baba

Frontiers in Oncology

doi 10.3389/fonc.2023.1260818

3,122 views
1 citation

Original Research

Published on 05 Oct 2023

Integrative analysis of triphenyl phosphate: contextual interpretation of bladder cancer cohort

in Cancer Immunity and Immunotherapy

Xiaolei Zhang
Wen Huang
Tao Huang
Jiayi Zhang
Aiming Xu
Yidong Cheng
Chao Qin
Qiang Lu
Zengjun Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1260114

2,201 views

Original Research

Published on 04 Oct 2023

A prognostic mathematical model based on tumor microenvironment-related genes expression for breast cancer patients

in Cancer Immunity and Immunotherapy

Hong Chen
Shan Wang
Yuting Zhang
Xue Gao
Yufu Guan
Nan Wu
Xinyi Wang
Tianyang Zhou
Ying Zhang
Di Cui

Frontiers in Oncology

doi 10.3389/fonc.2023.1209707

3,305 views
1 citation

Original Research

Published on 04 Oct 2023

Identification and validation of PCSK9 as a prognostic and immune-related influencing factor in tumorigenesis: a pan-cancer analysis

in Cancer Immunity and Immunotherapy

Chao Sun
Guoji Zhu
Conghuan Shen
Shungen Huang
Ruidong Li
Jianhua Li
Zhenyu Ma
Zhengxin Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1134063

3,956 views
10 citations

Original Research

Published on 02 Oct 2023

The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma

in Cancer Immunity and Immunotherapy

Xinyu Zhai
Xinglin Chen
Jianyi Gu
Dongdong Guo
Xiangyang Zhan
Mingyue Tan
Dongliang Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1256720

1,758 views

Original Research

Published on 02 Oct 2023

The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling

in Cancer Immunity and Immunotherapy

Song Li
Dianze Chen
Huiqin Guo
Dandan Liu
Chunmei Yang
Ruliang Zhang
Tianxiang Wang
Fan Zhang
Xing Bai
Yanan Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1240061

4,264 views
6 citations

Case Report

Published on 02 Oct 2023

Severe thyrotoxicosis induced by tislelizumab: a case report and literature review

in Cancer Immunity and Immunotherapy

Liman Huo
Chao Wang
Haixia Ding
Xuelian Shi
Bin Shan
Ruoying Zhou
Ping Liang
Juan Hou

Frontiers in Oncology

doi 10.3389/fonc.2023.1190491

3,075 views
3 citations

Original Research

Published on 02 Oct 2023

Inflammatory cell death induced by 5-aminolevulinic acid-photodynamic therapy initiates anticancer immunity

in Cancer Immunity and Immunotherapy

Lingyan Wang
Vipin Shankar Chelakkot
Nick Newhook
Stephanie Tucker
Kensuke Hirasawa

Frontiers in Oncology

doi 10.3389/fonc.2023.1156763

2,748 views
4 citations